ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma (vol 9, pg 396, 2018)

被引：0
|
作者：
Ojha, R.
Leli, N. M.
Onorati, A.
Piao, S.
Verginadis, I. I.
Tameire, F.
Chu, Charleen T.
机构：
来源：
CANCER DISCOVERY | 2019年 / 9卷 / 07期
关键词：
D O I：
10.1158/2159-8290.CD-19-0632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：981 / 981
页数：1
相关论文
共 37 条
  • [1] ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma
    Ojha, Rani
    Leli, Nektaria M.
    Onorati, Angelique
    Piao, Shengfu
    Verginadis, Ioannis I.
    Tameire, Feven
    Rebecca, Vito W.
    Chude, Cynthia I.
    Murugan, Sengottuvelan
    Fennelly, Colin
    Noguera-Ortega, Estela
    Liu, Shujing
    Xu, Xiaowei
    Krepler, Clemens
    Xiao, Min
    Xu, Wei
    Wei, Zhi
    Frederick, Dennie T.
    Boland, Genevieve
    Mitchell, Tara C.
    Karakousis, Giorgos C.
    Schuchter, Lynn M.
    Flaherty, Keith T.
    Zhang, Gao
    Herlyn, Meenhard
    Koumenis, Constantinos
    Amaravadi, Ravi K.
    CANCER DISCOVERY, 2019, 9 (03) : 396 - 415
  • [2] ER translocation of the entire MAPK pathway drives ERK reactivation and autophagy to promote therapy resistance in BRAF mutant cancers.
    Ojha, R.
    Leli, N. M.
    Onorati, A.
    Verginadis, I.
    Piao, S.
    Tameire, F.
    Rebecca, V.
    Fennelly, C.
    Chude, C. I.
    Koumenis, C.
    Amaravadi, R. K.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [3] Deleterious effects of MAPK pathway hyperactivation in BRAF-mutant melanoma
    Leung, Grace P.
    Feng, Tianshu
    Shirley, Matthew D.
    Sigoillot, Frederic D.
    Ruddy, David A.
    Freeman, Alyson K.
    Jaskelioff, Mariela
    Stuart, Darrin D.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant Melanoma
    Cohen, Justine, V
    Sullivan, Ryan J.
    CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5735 - 5742
  • [5] PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (vol 550, pg 133, 2017)
    Lu, Hezhe
    Liu, Shujing
    Zhang, Gao
    Wu, Bin
    Zhu, Yueyao
    Frederick, Dennie T.
    Hu, Yi
    Zhong, Wenqun
    Randell, Sergio
    Sadek, Norah
    Zhang, Wei
    Chen, Gang
    Cheng, Chaoran
    Zeng, Jingwen
    Wu, Lawrence W.
    Zhang, Jie
    Liu, Xiaoming
    Xu, Wei
    Krepler, Clemens
    Sproesser, Katrin
    Xiao, Min
    Miao, Benchun
    Liu, Jianglan
    Song, Claire D.
    Liu, Jephrey Y.
    Karakousis, Giorgos C.
    Schuchter, Lynn M.
    Lu, Yiling
    Mills, Gordon
    Cong, Yusheng
    Chernoff, Jonathan
    Guo, Jun
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Wei, Zhi
    Field, Jeffrey
    Amaravadi, Ravi K.
    Flaherty, Keith T.
    Herlyn, Meenhard
    Xu, Xiaowei
    Guo, Wei
    NATURE, 2019, 565 (7738) : E4 - E4
  • [6] Role of IGF1R in mediating resistance to MAPK pathway inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Mishra, Rosalin
    Broit, Natasa
    Yacoub, Nour
    Yuan, Long
    Alanazi, Samar
    Hayward, Nicholas
    Johansson, Peter
    Garrett, Joan T.
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
    Long, Georgina V.
    Fung, Carina
    Menzies, Alexander M.
    Pupo, Gulietta M.
    Carlino, Matteo S.
    Hyman, Jessica
    Shahheydari, Hamideh
    Tembe, Varsha
    Thompson, John F.
    Saw, Robyn P.
    Howle, Julie
    Hayward, Nicholas K.
    Johansson, Peter
    Scolyer, Richard A.
    Kefford, Richard F.
    Rizos, Helen
    NATURE COMMUNICATIONS, 2014, 5
  • [8] Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
    Georgina V. Long
    Carina Fung
    Alexander M. Menzies
    Gulietta M. Pupo
    Matteo S. Carlino
    Jessica Hyman
    Hamideh Shahheydari
    Varsha Tembe
    John F. Thompson
    Robyn P. Saw
    Julie Howle
    Nicholas K. Hayward
    Peter Johansson
    Richard A. Scolyer
    Richard F. Kefford
    Helen Rizos
    Nature Communications, 5
  • [9] PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
    Lu, Hezhe
    Liu, Shujing
    Zhang, Gao
    Wu, Bin
    Zhu, Yueyao
    Frederick, Dennie T.
    Hu, Yi
    Zhong, Wenqun
    Randell, Sergio
    Sadek, Norah
    Zhang, Wei
    Chen, Gang
    Cheng, Chaoran
    Zeng, Jingwen
    Wu, Lawrence W.
    Zhang, Jie
    Liu, Xiaoming
    Xu, Wei
    Krepler, Clemens
    Sproesser, Katrin
    Xiao, Min
    Miao, Benchun
    Liu, Jianglan
    Song, Claire D.
    Liu, Jephrey Y.
    Karakousis, Giorgos C.
    Schuchter, Lynn M.
    Lu, Yiling
    Mills, Gordon
    Cong, Yusheng
    Chernoff, Jonathan
    Guo, Jun
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Wei, Zhi
    Field, Jeffrey
    Amaravadi, Ravi K.
    Flaherty, Keith T.
    Herlyn, Meenhard
    Xu, Xiaowei
    Guo, Wei
    NATURE, 2017, 550 (7674) : 133 - +
  • [10] PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
    Hezhe Lu
    Shujing Liu
    Gao Zhang
    Yueyao Bin Wu
    Dennie T. Zhu
    Yi Frederick
    Wenqun Hu
    Sergio Zhong
    Norah Randell
    Wei Sadek
    Gang Zhang
    Chaoran Chen
    Jingwen Cheng
    Lawrence W. Zeng
    Jie Wu
    Xiaoming Zhang
    Wei Liu
    Clemens Xu
    Katrin Krepler
    Min Sproesser
    Benchun Xiao
    Jianglan Miao
    Claire D. Liu
    Jephrey Y. Song
    Giorgos C. Liu
    Lynn M. Karakousis
    Yiling Schuchter
    Gordon Lu
    Yusheng Mills
    Jonathan Cong
    Jun Chernoff
    Genevieve M. Guo
    Ryan J. Boland
    Zhi Sullivan
    Jeffrey Wei
    Ravi K. Field
    Keith T. Amaravadi
    Meenhard Flaherty
    Xiaowei Herlyn
    Wei Xu
    Nature, 2017, 550 : 133 - 136
1234